Thomas Davis - Dec 31, 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Thomas Davis
Stock symbol
GNCA
Transactions as of
Dec 31, 2021
Transactions value $
-$3,738
Form type
5
Date filed
3/16/2022, 05:29 PM
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$2.57K -948 -1.89% $2.71 49.2K Apr 2, 2021 Direct F1
transaction GNCA Common Stock Sale -$1.17K -524 -1.06% $2.23 48.7K Jun 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.